After years of overtreatment for patients with low-risk prostate cancer, rates of active surveillance/ watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with ...
Jul 7, 2015
0
4
(HealthDay)—For patients with prostate cancer treated with androgen deprivation therapy there are increases in components of metabolic syndrome and in the prevalence of full metabolic syndrome, according to a study published ...
Jun 4, 2015
0
3
(HealthDay)—Primary androgen deprivation therapy increases diabetes risk, particularly in men under 70 years of age, according to research published in the June issue of The Journal of Urology.
May 28, 2015
0
40
New research led by the University of Warwick shows newly diagnosed advanced prostate cancer patients who received the chemotherapy drug docetaxel with standard hormone therapy lived ten months longer on average, compared ...
May 14, 2015
0
14
Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is commonly called "chemo brain." ...
May 13, 2015
0
4
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. ...
May 8, 2015
0
21
Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical ...
May 7, 2015
0
23
There's nothing like napping on the couch during a lazy weekend or lounging cozily while watching your favorite sporting event on television.
May 1, 2015
0
5
Preliminary results of a study of patients with prostate cancer show that MR tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation ...
Apr 24, 2015
0
6
While testosterone replacement therapies may be controversial in males, new research in The FASEB Journal may extend this controversy to females too. That's because research involving mice, appearing in the April 2015 issue, ...
Apr 1, 2015
0
5
